Prevalencia de anticuerpos contra SARS-CoV-2 en pacientes con cáncer y trabajadores de la salud vacunados con dos dosis de BNT162b2 o AZD122. Análisis de propensión / Prevalence of SARS-CoV-2 antibodies in cancer patients and healthcare workers vaccinated with two doses of BNT162b2 or AZD122. A propensity analysis

Resumen Antecedentes: La vacunación es la intervención más efectiva para reducir la carga de enfermedad por SARS-CoV-2; sin embargo, persisten brechas en el conocimiento en relación con la respuesta inmunológica de los pacientes con cáncer (PC). Objetivos: Evaluar la respuesta humoral (anticuerpos anti-S) en PC y trabajadores de salud (TS) vacunados con dos dosis de la vacuna BNT162b2 o AZD122. Material y métodos: Se cuantificaron anticuerpos poliespecíficos contra la proteína de espiga de SARS-CoV-2 (anti-S) y se efectuó una puntuación de propensión 1:1 para equilibrar las características basales. Se realizaron regresiones logísticas múltiples para evaluar el efecto de las variables relacionadas con la respuesta humoral. Resultados: Se incluyeron 127 PC (22 %) y 439 TS (78 %). Ambas poblaciones desarrollaron anticuerpos anti-S en respuesta a la vacunación. La vacuna de ARNm (BNT162b2) se asoció a mayor probabilidad de mostrar concentraciones de anticuerpos anti-S ≥ 1000 UI/mL, mientras que el cáncer activo se relacionó con menor probabilidad de presentar títulos altos de anticuerpos. Conclusiones: La vacuna BNT162b2 se asoció a respuesta humoral mayor. Es necesario contar con más información y estrategias de vacunación en pacientes inmunosuprimidos. Es relevante la selección de los mejores biológicos para esta población y considerar las características individuales.

Abstract Background: Vaccination is the most effective intervention for reducing the burden of SARS-CoV-2-related disease; however, gaps in knowledge regarding cancer patients (CPs) immune response persist. Objectives: To evaluate the humoral response (anti-S antibodies) in CPs and healthcare workers (HCWs) vaccinated with two doses of BNT162b2 or AZD122 vaccines. Material and methods: Polyspecific anti-SARS-CoV-2 spike protein (anti-S) antibodies were quantified, and a 1:1 propensity score was used to balance baseline characteristics. Multiple logistic regressions were carried out to evaluate the effect of humoral response-related variables. Results: One-hundred and twenty-seven CPs (22 %) and 439 HCWs (78 %) were included. Both populations developed anti-S antibodies in response to vaccination. The mRNA-based vaccine (BNT162b2) was associated with higher odds of having anti-S antibody titers ≥ 1,000 U/mL, while active cancer was related to a lower probability of developing high antibody titers. Conclusions: The BNT162b2 vaccine was associated with a higher humoral response. It is necessary for more information and vaccination strategies to be available for immunosuppressed patients in order to select the best biologics for this population based on individual characteristics.

Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19

BACKGROUND Patients with severe coronavirus disease 2019 (COVID-19) often present with coagulopathies and have high titres of circulating antibodies against viral proteins. OBJECTIVES Herein, we evaluated the association between D-dimer and circulating immunoglobulin levels against viral proteins in patients at different clinical stages of COVID-19. METHODS For this, we performed a cross-sectional study involving patients of the first wave of COVID-19 clinically classified as oligosymptomatic (n = 22), severe (n = 30), cured (n = 27) and non-infected (n = 9). Next, we measured in the plasma samples the total and fraction of immunoglobulins against the nucleoprotein (NP) and the receptor-binding domain (RBD) of the spike proteins by enzyme-linked immunosorbent assay (ELISA) assays. FINDINGS Patients with severe disease had a coagulation disorder with high levels of D-dimer as well as circulating IgG against the NP but not the RBD compared to other groups of patients. In addition, high levels of D-dimer and IgG against the NP and RBD were associated with disease severity among the patients in this study. MAIN CONCLUSIONS Our data suggest that IgG against NP and RBD participates in the worsening of COVID-19. Although the humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is partially understood, and more efforts are needed to clarify gaps in the knowledge of this process.

Enhancement of anti-OVA IgG2c production in vivo by enalapril

Angiotensin-converting enzyme (ACE) inhibitors have non-hemodynamic, pleiotropic effects on the immune response. The effects of ACE inhibitors on the production of cytokines and T-cell functions are well established. However, little is known on the effects of these medicines on humoral response to foreign antigens. In this study, we investigated the effect of enalapril treatment on ovalbumin (OVA)-specific IgG1 and IgG2c production in mice determined by ELISA. Two groups of 8-week-old C57BL/6 females mice (3–4/group) were subcutaneously immunized with OVA (10 μg/animal) in presence of Alhydrogel (1 mg/mouse) and boosted at day 21. The mice were treated with enalapril (5 mg/kg daily, po) or were left without treatment for one month. The animals were bled from the orbital plexus on days 0, 7, 14, 21, and 28 after the first immunization and the sera were stored at –20°C until usage. OVA-specific serum IgG1 and IgG2c were determined by ELISA using serum from each individual animal. The results showed that enalapril significantly increased anti-OVA serum IgG2c in the secondary response without affecting IgG1 synthesis. These data expand our understanding on the properties of enalapril on the immune response, including antibody production.

Humoral Response against Native Plasmodium berghei Hemozoin and Synthetic Hemozoin in BALB/c Mice.

Aims: Malaria is a disease caused by protozoan parasites of the genus Plasmodium. One of the malaria mechanisms of adaptation to the host is the digestion of hemoglobin by the trophozoite stage. This mechanism provides the amino acids needed by the parasite and is carried out during the erythrocytics schozogony phase, which results in the formation of in soluble pigment crystals named hemozoin (Hz). Hz is responsible for many of the immune pathological complications of malaria, given that this pigment accumulates in various organs in severe cases of the disease. Here, we evaluated the humoral response in BALB/c mice against native Plasmodium berghei Hz (PbHz) and synthetic Hz (SHz). Place and Duration of Study: Laboratory of Immunology of Infection Diseases. Department of Cell Biology, Simón Bolívar University, Caracas, Venezuela. This study was performed between January 2012 and June 2012. Methodology: We determined the humoral response of SHz and PbHz by an enzyme linked immunosorbent assay (ELISA), using hyper-immune sera from mice experimentally infected with P. berghei or Plasmodium yoelii. In addition, SHz was evaluated as antigen by Western Blot and dot-ELISA. Results: When SHz was employed as antigen, we showed by indirect ELISA that the sera from mice immunized with SHz generated higher titers than sera obtained from mice infected with either Plasmodium species. Moreover, the sera from human infections also recognized SHz as antigen, but showed a better recognition by dot- ELISA or Western Blot than by indirect ELISA. Conclusion: In summary, our results indicated that SHz can be used as a rapid and successful diagnostic antigen for natural malaria infections by indirect ELISA, dot-ELISA and Western Blot techniques.

Humoral response and evolution of Echinococcus infection in experimentally infected sheep / Resposta humoral e evolução à infecção por Echinococcus em ovinos experimentalmente infectados

There is little information on the humoral response of sheep experimentally infected with Echinococcus granulosus. Thus, the objective of this study was to evaluate this response and measure its evolution. Doses of 10, 100, 1000 and 10000 E. granulosus eggs were prepared and inoculated via intraruminal puncture. Blood samples were obtained before inoculation and every 48 h after inoculation, until they became seropositive. Thereafter, they were taken monthly for the first year and then every three months until 1700 days of observation had been completed. An ELISA test, with total hydatid fluid antigen, was used for immunodiagnosis. The average optical density of the 12 inoculated sheep was found to be above the mean cutoff value 10 days after inoculation, went on increasing until 180 days after inoculation and remained above the cutoff level until the end of the observation period. This confirms that the antibody response of sheep to E. granulosus infection occurs before production of hydatid fluid and that activation, mobilization and establishment of oncospheres in the tissues generates a persistent response from the host's immune system.

Existe pouca informação sobre a resposta imune humoral de ovinos experimentalmente infectados por Echinococcus granulosus. O objetivo deste estudo é avaliar a resposta imune por anticorpos em ovinos infectados. Os ovinos receberam doses de 10, 100, 1.000 e 10.000 ovos de E. granulosus por via intrarruminal. Amostras de sangue foram colhidas antes e após infecção, a cada 48 horas, até a detecção de anticorpos anti-E. granulosus e após, colheram-se amostras mensal e trimestralmente, no primeiro ano até 1.700 dias de infecção. No imunodiagnóstico, utilizou-se o ensaio imunoenzimático indireto (ELISA-teste) e como antígeno total, líquido hidático. Na detecção de anticorpos anti-E. granulosus no soro das 12 ovelhas, a densidade ótica esteve acima do ponto de corte, após 10 dias de infecção, aumentando até 180 dias pós-infecção, e permanecendo acima desses dias até o final do experimento. Isso confirma que a resposta por anticorpos em ovinos infectados por E. granulosus antecede a produção de líquido hidático, e que a ativação, mobilidade e permanência das oncosferas nos tecidos possibilita a resposta imune dos hospedeiros.

IgG Antibody responses in mice coinfected with Toxocara canis and other helminths or protozoan parasites / Anticorpos IgG em camundongos coinfectados por Toxocara canis e outros helmintos e por protozoários parasitos

The immune response expressed by IgG antibodies in BALB/c mice experimentally infected with Toxocara canis, was studied with the aim of verifying the possible in vivo cross-reactivity between antigens of T. canis and other parasites (Ascaris suum, Taenia crassiceps, Schistosoma mansoni, Strongyloides venezuelensis and Toxoplasma gondii). Experiments included three groups of mice: one infected only by T. canis, another with one of the other species of parasites and a third concomitantly infected with T. canis and the other species in question. Animals were bled by orbital plexus at 23, 38 and 70 days post infection (p.i.). Sera were analyzed for anti-Toxocara antibodies by ELISA and Immunoblotting, using excretion-secretion antigens (ES), obtained from culture of third-stage larvae of T. canis. For all experiments a control group comprised by ten non-infected mice was used. Only in the case of A. suum infection, in these experimental conditions, the occurrence of cross-reactivity with T. canis was observed. However, in the case of co-infection of T. canis - S. mansoni, T. canis - S. venezuelensis and T. canis - T. crassiceps the production of anti-Toxocara antibodies was found at levels significantly lower than those found in mice infected with T. canis only. Co-infection with S. mansoni or S. venezuelensis showed lower mortality rates compared to what occurred in the animals with single infections. Results obtained in mice infected with T. canis and T. gondii showed significant differences between the mean levels of the optical densities of animals infected with T. canis and concomitantly infected with the protozoan only in the 23rd day p.i.

Estudou-se a resposta imune humoral expressa por anticorpos da classe IgG em camundongos BALB/c experimentalmente infectados com Toxocara canis em duas situações distintas. Na primeira, com o objetivo de verificar in vivo a possível reatividade cruzada entre Toxocara canis e outros parasitos (Ascaris suum, Taenia crassiceps, Schistosoma mansoni, Strongyloides venezuelensis e Toxoplasma gondii), foram realizados experimentos constituídos por três grupos de camundongos: um infectado apenas por Toxocara canis, outro com uma das demais espécies de parasitos estudados e um terceiro concomitantemente infectado por Toxocara canis e a espécie em questão. Todos os animais foram sangrados, através do plexo orbitário, 23, 38 e 70 dias após infecção. Os soros foram analisados para a presença de anticorpos anti-Toxocara por meio de teste imunoenzimático (ELISA) e por Immunoblotting, empregando-se antígeno de excreção-secreção (ES), obtido a partir da cultura de larvas de terceiro estádio de Toxocara canis. Para todos os experimentos utilizou-se grupo controle negativo constituído por 10 camundongos não infectados. Apenas no caso da infecção por Ascaris suum, nas condições experimentais observadas, logrou-se demonstrar ocorrência de reatividade cruzada com antígenos de Toxocara canis. Verificou-se, entretanto, no caso das coinfecções entre Toxocara canis-Schistosoma mansoni, Toxocara canis-Strongyloides venezuelensis e Toxocara canis-Taenia crassiceps produção de anticorpos anti-Toxocara em níveis significativamente inferiores do que os encontrados nos camundongos infectados somente por Toxocara canis. Nas coinfecções com Schistosoma mansoni ou Strongyloides venezuelensis observou-se, também, menor taxa de letalidade quando comparada à ocorrida nos animais com as respectivas infecções simples.

Immunomodulatory effects of alcoholic and hydroalcoholic extracts of Moringa olifera Lam leaves.

Effects of 50, 100 and 200 mg/kg body weight of the alcoholic and hydro-alcoholic extract of leaves of M. olifera were studied on various immune paradigms like delayed type hypersensitivity reaction using SRBC as an antigen, determination of antibody titer, neutrophil adhesion test as an indicator for neutrophil index, total leucocyte count in cyclophosphamide induced immunosuppressed animals and carbon clearance assay as a measure of phagocytic activity. Hydro-alcoholic extract of M. olifera substantially enhanced cellular immune response, humoral immune response, neutrophil index and phagoctic activity in doses of 100 and 200 mg/kg body weight. The ethanolic extract (200 mg/kg body wieght) was efficient in improving immune response. The results suggest that M. olifera has a significant role to play as an immune stimulator.

Resposta humoral, carga parasitária e avaliação histopatológica na infecção experimental por Leishmania (Leishmania) chagasi em camundongos BALB/c imunossuprimidos / Humoral response, parasite load and histopathological evaluation in immunossuppressed BALB/c mice experimentally infected by Leishmania (Leishmania) chagasi

O objetivo do estudo foi avaliar a resposta humoral, a carga parasitária e os aspectos histopatológicos presentes no fígado em camundongos BALB/c experimentalmente infectados por L. (L.) chagasi e imunossuprimidos. 96 camundongos foram subdivididos em quatro grupos: controle (I) – sem tratamento; imunossuprimidos (II) – tratamento com dexametasona (DXM) e pentoxifilina (PTX); infectado (III) – infecção por L (L.) chagasi e infectados e imunossuprimidos (IV) - infecção por L (L.) chagasi e tratados com DXM e PTX. O dia de infecção foi considerado como o dia zero e a imunossupressão ocorreu 60 dias pós-infecção. As amostras foram obtidas de cada grupo, em momentos distintos 15, 30, 60, 75 e 90 dias pós-infecção, em que se coletou sangue total, para detecção de IgG1 e IgG2a pelo ensaio imunoenzimático (ELISA), fragmentos de baço e fígado, para detecção da carga parasitária pela técnica de microtitulação em cultura e fragmentos de fígado para o exame histopatológico. Houve diferença significativa na produção das imunoglobulinas e IgG1 foi à subclasse de imunoglobulina mais produzida pelos grupos (P < 0,0001). Quando comparadas a subclasses de imunoglobulinas dentro do mesmo grupo, IgG1 também apresentou médias maiores de produção nos grupos III e IV (P = 0,014 e P = 0,009). E quando se considera o momento, não houve diferenças significativas entre IgG1 e IgG2a. Aos 90 dias pós-infecção foram encontradas diferenças significativas entre as médias de produção de IgG1 e IgG2a, entre os grupos III e IV e o grupo III produziu mais as duas subclasses (P = 0,02). Nos momentos 75 e 90 dias pós-infecção houve produção maior de IgG1 e IgG2a. O Grupo IV apresentou maior carga parasitária (P < 0,005).(...)

This study aimed to evaluate the humoral response, the parasite load and liver histopathological features in BALB/c experimentally infected by L. (L.) chagasi and immunosuppressed Ninety-six mice divided into four groups: control (I) - no treatment; immunosuppressed (II) - Treatment with dexamethasone (DXM) and pentoxifylline (PTX), infected (III) - infection by L. (L.) chagasi and infected and immunosuppressed (IV) - infection by L (L.) chagasi and treated with PTX and DXM. The days of infection was considered as day zero and immunosuppression occurred 60 days post-infection. Samples were obtained from each group at different times 15, 30, 60, 75 and 90 days post-infection, which collected whole blood for detection of IgG1 and IgG2a by test immunoassay (ELISA), fragments of spleen and liver, to detect the parasite load in the technique microtiter culture and fragments of liver for histopathology. Significant differences in production of immunoglobulins, IgG1 was the subclass immunoglobulin produced by most groups (P<0.0001). When comparing the immunoglobulin subclasses within the same group, IgG1 also showed higher average production in groups III and IV (P=0.014 and P=0.009). When one considers the time, there were no significant differences between IgG1 and IgG2a. At 90 days post-infection were significant differences between the means of production of IgG1 and IgG2a between group III and IV and group III produced over the two subclasses (P=0.02). In periods of 75 and 90 days post-infection there was increased production of IgG1 and IgG2a. Group IV showed a higher parasite load (P <0.005).(...)

Humoral response of paracoccidioidomycosis sera in hamsters with different Venezuelan isolates

Humoral response of paracoccidioidomycosis sera in hamsters with different Venezuelan isolates. Paracoccidioidomycosis (PCM) is a progressive systemic mycosis caused by the fungus Paraccocidioides brasiliensis (Pb), endemic to Venezuela and Latin America. In this study, eight different Venezuelan isolates obtained from patients with PCM, were inoculated intraperitoneally in Syrian hamsters (Cricetus auratus) and studied by immune-serum. Each strain was collected by gently scraping the surface of the culture medium (Sabouraud Dextrose Agar) and suspended in 3ml of 0.15 M phosphate-buffered saline. The antigen obtained was called Paraccocidioides brasiliensis Crude Antigen (CAP). Immunoblotting results showed that the immune-sera from hamsters recognized at least 3 bands: one over 200 kDa, and two of 80 and 15-20 kDa. This study suggests that IgG anti-CAP can reveal a significant variability in the eight Venezuelan isolates. Sera from 88 infected hamsters were evaluated by ELISA with eight different CAPs and Western blot with CAP 37383. ELISA results showed that, the antigen of the virulent isolate 37383 had the highest percentage (38%) of positivity, while the non-virulent isolate 1458 had the lowest one (13.6%). Furthermore, scanning densitometry revealed that the isolate 37383 had less bands than the non-virulent isolates. These results suggest that the ELISA test with CAP 37383 can detect circulating antibodies, and that this virulent isolate may be useful for the diagnosis of PCM, and to monitor disease responses to treatments. Rev. Biol. Trop. 57 (3): 505-513. Epub 2009 September 30.

La Paracoccidioidomicosis (PCM), es una micosis sistémica causada por el hongo Paraccocidioides brasiliensis (Pb), endémica en Venezuela y Latino América. En este estudio ocho diferentes aislados venezolanos, obtenidos de pacientes con PCM, fueron inoculados intraperitonealmente en hámsteres y fueron estudiados por ELISA e inmunoblotting. Los antígenos obtenidos de P. brasiliensis fueron llamados, Antígeno Crudo (CAP). Los resultados del immunoblotting mostraron que los sueros inmunes de hámsteres reconocieron al menos tres bandas: una sobre 200, y otras de 80, y 15-20 kDa. Este estudio sugiere que la IgG anti-CAP muestra una variabilidad en los ocho aislados Venezolanos. Sueros de 88 hámsteres infectados fueron evaluados usando ELISA, el antígeno del aislado virulento 37383 mostró el más alto porcentaje de positividad (38%) en los sueros de los hámsteres estudiados. El aislado novirulento 1458 mostró un porcentaje bajo de positividad (13.6%). Además, un escaneo densitométrico reveló que el aislado 37383 tiene menos bandas que el otro aislado no-virulento. Por lo tanto, estos resultados sugieren que el ensayo de ELISA con CAP 37383 puede detectar anticuerpos circulantes y este aislado virulento puede ser útil para el diagnostico de PCM, y para el monitoreo de la respuesta al tratamiento de la enfermedad.

Vacina de DNA: aspectos gerais e sua aplicação na medicina humana e veterinária / DNA vaccines: general concerns and its applications in human and veterinary medicine

A vacinação com DNA é uma das mais promissoras técnicas de imunização contra uma variedade de patógenos e tumores, para os quais os métodos convencionais não tem sido eficientes. Vacinas de DNA são capazes de induzir resposta imune humoral e celular, tanto para resposta de linfócitos CD4 + quanto CD8 +, sem a necessidade de microrganismos vivos. Apesar do grande potencial de induzir imunidade protetora, a vacina de DNA nem sempre apresenta bons resultados. A imunidade depende de vários fatores como a seleção do gene alvo, construção do vetor de expressão, freqüência e via de administração da vacina, quantidade de DNA, localização do antígeno codificado pelo plasmídio e idade, saúde e espécies de animais vacinados. Esta revisão relata o desenvolvimento de algumas vacinas de DNA para doenças de interesse na medicina veterinária e humana.

The vaccination with DNA is one of the most promising immunization techniques against a pathogensvariety and tumors, for which the conventional methods have not been efficient. DNA vaccines arecapable to induce immune humoral and cellular response, directed to lymphocytes CD4+ and CD8+,without the necessity of live microorganisms. In spite of the great potential of inducing protectiveimmunity, the DNA vaccine not always has success. The immunity depends on several factors such asthe selection of the target gene, construction of the expression vector, frequency and via of administrationof the vaccine, amount of DNA, location of the antigen codified by the plasmid and age, health andspecies of vaccinated animals. This revision shows the development of some vaccines of DNA fordiseases of interest in the veterinary and human medicine.